Back
Altimmune Quote, Financials, Valuation and Earnings
Sponsored
ALT
Sponsored
Invest. Do Good. Get Rewarded. Just $0.26/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
70
ALT
Altimmune
Last Price:
8.66
Seasonality Move:
25.96%
7 Day Trial
ALL ACCESS PASS
$
7
Say this - unlock as much as $1,250 every Friday
Click here for full details.Altimmune Price Quote
$8.66
-0.02 (3.03%)
(Updated: November 23, 2024 at 5:24 AM ET)
Altimmune Key Stats
Buy
70
Altimmune (ALT)
is a Buy
Day range:
$8.28 - $8.84
52-week range:
$2.50 - $14.84
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
11,322.01
P/B ratio:
4.63%
Volume:
2.2M
Avg. volume:
3.4M
1-year change:
239.06%
Market cap:
$617.4M
Revenue:
$426K
EPS:
$-1.57
How Much Does Altimmune Make?
Is Altimmune Growing As A Company?
Altimmune Stock Price Performance
What Is Altimmune 52-Week High & Low?
Altimmune Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Altimmune?
Is Altimmune Cash Flow Positive?
Altimmune Return On Invested Capital
Altimmune Earnings Date & Stock Price
-
What Is Altimmune's Stock Price Today?
A single share of ALT can be purchased today for 8.68 -
What Is Altimmune’s Stock Symbol?
Altimmune trades on the nasdaq under the ticker symbol: ALT -
When Is Altimmune’s Next Earnings Date?
The next quarterly earnings date for Altimmune is scheduled on March 27, 2025 -
When Is ALT's next ex-dividend date?
Altimmune's next ex-dividend date is January 20, 2017 -
How To Buy Altimmune Stock?
You can buy Altimmune shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Altimmune Competitors
Altimmune Dividend Yield
-
What Is ALT Dividend Yield?
Altimmune’s dividend yield currently is 0% -
What Is Altimmune’s Payout Ratio?
Altimmune’s payout ratio is 0% -
When Did Altimmune Last Pay A Dividend?
The latest dividend pay date is November 24, 2024 -
What Is Altimmune’s Dividend Per Share?
Altimmune pays a dividend of $0.00 per share
Altimmune Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | 10.5% |
Revenue: | -98.62% | 706.45% |
Analyst Recommendations
Buy Recommendations: | 4 |
---|---|
Hold Recommendations: | 2 |
Sell Recommendations: | 0 |
Price Target: | 21.25 |
Upside from Last Price: | 144.82% |